(IN BRIEF) Boehringer Ingelheim has entered into a global collaboration and licensing agreement with Palatin Technologies to develop melanocortin receptor agonists as a new treatment for retinal diseases, beginning with diabetic retinopathy and diabetic macular edema. The approach targets inflammation, … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged biopharmaceutical collaboration, Boehringer Ingelheim, Carl Spana, diabetic macular edema, diabetic retinopathy, eye health innovation, inflammation, licensing agreement, melanocortin receptor agonists, neurodegeneration, Palatin Technologies, parttnership, Remko Bakker, Retinal Disease Treatment, vascular dysfunction, Vision Preservation, €280 million milestone payments
(IN BRIEF) The University of Liverpool has launched the Liverpool Interdisciplinary Neuroscience Centre (LINC), an ambitious collaboration uniting nearly 170 researchers and clinicians from the University, The Walton Centre NHS Foundation Trust, Brain Health Northwest, and global partners. LINC aims … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged Alder Hey Children’s NHS Foundation Trust, brain health, Brain Health Northwest, brain tumours, British Neuroscience Association, chronic pain, David Fairclough, diagnostics, Dr Andy Nicolson, epilepsy, Epilepsy Research Institute, interdisciplinary research, LINC, Liverpool Interdisciplinary Neuroscience Centre, mental health, Mersey Care, neurodegeneration, neurological disorders, neurosurgery, Professor Benedict Michael, Professor Louise Kenny, Psychiatry, Roche Diagnostics UK & Ireland, The Walton Centre NHS Foundation Trust, therapies, University of Liverpool, WHO Global Action Plan
(IN BRIEF) The University of Dundee has named Professor Miratul Muqit as inaugural Director of the UK Dementia Research Institute’s Parkinson’s Research Centre. Funded with £10 million, the centre aims to develop new predictive tools, preventive strategies, and treatments to … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged appointment, Dario Alessi, disease-modifying therapies, leadership, mitochondrial damage, MRC-PPU, neurodegeneration, Parkin, Parkinson’s Research Centre, Parkinson’s UK, Phase 1 trials, PINK1, predictive tools, Prevention Strategies, Professor Miratul Muqit, UK Dementia Research Institute, University of Dundee, University of Edinburgh, £10 million funding
(PRESS RELEASE) ENSCHEDE, Netherlands, 28-Feb-2022 — /EuropaWire/ — University of Twente, a Enschede, NL based public technical university, has announced that its associate professor Kerensa Broersen has been granted Vici funding from NWO, the Dutch Research Council. Kerensa Broersen, associate … Read the full press release
Posted in Education, Financial, Healthcare, Netherlands, Science, Technology
Tagged autism spectrum disorders, Brain, brain function, brain tumours, brain-related disorders, intestinal bacteria, Kerensa Broersen, multiple sclerosis, neurodegeneration, NWO, Parkinson's disease, schizophrenia, Stem cells, TTW, Veni, Vici funding, Vici grant, Vidi grants, ZonMw
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?